Interleukin 10 treatment for rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 58, Issue SUPPL. 1, 1999, Pages

  St Clair, E William ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HUMAN; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; INTERLEUKIN-10; RECOMBINANT PROTEINS;

EID: 0032705931     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
2. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-a in humanmonocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
3. Parry SL, Sebbag M, Feldmann M, Brennan FM. Contact with T cells modulates monocyte IL-10 pruduction. Role of T cell membrane TNF-α. J Immunol 1997;158:3673-81.
4. Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 1995;155:4926-32.
5. +T cells and monocytes. Blood 1996;87:4731-6.
6. Porrini AM, Gambi D, Reder AT. Interferon effects on iriterleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J Neuroimmunol 1995;61:27-34.
7. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998;161:2586-93.
8. Sutterwala FS, Noel GJ, Salgame P, Mosser DM. Reversal of proinflammatory responses by ligating the macrophage Fcy receptor type I. J Exp Med 1998;188:217-22.
9. Chomarat P, Rissoan M, Banchereau J, Miossec P. Interferon γ inhibits interleukin 10 production by monocytes. J Exp Med 1993;177:523-7.
10. Bonder CS, Finlay-Jones JJ, Hart PH. Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 γ-chain. Immunology 1999;96:529-36.
11. Dugas N, Vouldoukis I, Becherel P, et al. Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin 10 production by human macrophages. Eur J Immunol 1996;26:1394-8.
12. Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 1997;40:2105-15.
13. b1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-γ or IL-2 determines their function. Int Immunol 1995;7:1287-94.
14. Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW. Regulation of hyaluronan induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophges. J Immunol 1998;160:3023-30.
15. Sherry B, Espinoza M, Manogue KR, Cerami A. Induction of the chemokine β peptides, MIP-Iä and MIP-Iβ, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines γIFN, IL-10, IL-4, and TGF-β. Mol Med 1998;4:648-57.
16. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
17. Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993;23: 1034-8.
18. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM. Interleukin-10 suppression of monocyte prostaglandin H synthase-2. J Biol Chem 1994;269:21322-9.
19. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994;24: 2699-705.
20. Jenkins JK, Malyak M, Arend WP. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine and Cytokine Research 1994;13: 47-54.
21. Fiorentino DF, Zlotnik A, Vicira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.
22. Willems F, Marchant A, Delville J, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994;24: 1007-9.
23. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 1998;160:5936-44.
24. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89: 1890-3.
25. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM. Interleukin 10: a novel immunostimulatory factor for mast cells and their progenitors. J Exp Med 1991;173:507-10.
26. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnick A. IL-10, a novel growth factor for mature and immature T cells. J Immunol 1990;145:4167-73.
27. Jeannin P, Lecoanet S, Delneste Y, Gauchat J, Bonnefoy J. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998;160:3555-61.
28. Levy Y, Brouet J. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bel 2 protein. J Clin Invest 1994;93:424-8.
29. Powric F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993;23:2223-9.
30. Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and interleukin-10 exacerbate candidiasis in mice. Eur J Immunol 1995;25:1559-65.
31. Kelly JP, Bancroft GJ. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol 1996;26:356-64.
32. Hagenbaugh A, Sharma S, Dubinett SM, et al. Altered immune responses in interleukin 10 transgenic mice. J Exp Med 1997;185:2101-10.
33. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997;158:315-21.
34. Groux H, Cottrez F, Rouleau M, et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol 1999;162:1723-9.
35. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992;149:12416-505.
36. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyclitis in rats. Eur J Immunol 1994;24:1434-40.
37. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994;71:169-75.
38. Wogensen L, Lee M, Sarvetnik N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994;179: 1379-84.
39. Lee M, Wogensen L, Shizuru J, Oldstone MBA, Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994;93:1332-8.
40. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin 10 expression and chemokine regulation during the evolution of murine type II collagen induced arthritis. J Clin Invest 1995;95:2868-76.
41. Walmsley M, Katsikis PD, Abney E, et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996;39:495-503.
42. Joosten LAR, Lubberts E, Durez P, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
43. Kasama T, Yamazaki J, Hanaoka R, et al. Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12. Possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha. Arthritis Rheum 1999;42:100-9.
44. Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
45. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995;38:1046-54.
46. Kawakami A, Eguchi K, Matsuoka N, et al. Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis. Immunology 1947;91:252-9.
47. Cohen SBA, Katsikis PD, Chu C, et al. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 1995;38:946-52.
48. Morita Y, Yamamura M, Kawashima M, et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 1998; 41:1669-70.
49. Reparon-Schuiji CC, van Esch WJE, van Kooten C, Levarht EWN, Breedveld FC, Verweij CL. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum 1998;41: 2211-20.
50. Cush JJ, Splawski TB, Thomas R, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
51. Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
52. van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reveral of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
53. Hart PH, Hunt EK, Bonder CS, Watson CJ, Finlay-Jones JJ. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4and IL-10. J Immunol 1996;157:3672-80.
54. Llorente L, Richaud-Patin Y, Fior R, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994;37:1647-55.
55. Chernoff AK, Granowitz EV, Shapiro L, et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses J Immunol 1995;154:5492-9.
56. Maini RN, Paulus H, Breedveld FC, et al. rHuIL-10 in subjects with active rheumatoid arthritis (RA): A phase I and cytokine response study. Arthritis Rheum 1997;40(suppl): S224.